@article{27be7c4ab2b943168dabea9812e8646c,
title = "Depression and ART Initiation Among HIV Serodiscordant Couples in Kenya and Uganda",
abstract = "Depression is a known barrier for antiretroviral therapy (ART) adherence, but less is understood about its effects on ART initiation. We followed 1013 HIV-infected individuals participating in the Partners Demonstration Project, an open-label study of integrated pre-exposure prophylaxis (PrEP) and ART delivery for HIV serodiscordant couples in Kenya and Uganda. Associations between depression, measured annually with the Hopkins Symptoms Checklist-Depression (HSCL-D), and ART initiation were assessed with Cox proportional hazards regression. At enrollment, 162 participants (16.0%) reported symptoms consistent with probable depression, defined by a HSCL-D mean score >1.75, and this proportion decreased during study follow-up (6.7 and 3.6% at 12- and 24-months, respectively; p value < 0.001). Greater depressive symptom severity was associated with a greater likelihood of ART initiation overall (adjusted hazard ratio [aHR] 1.32, 95% CI 1.01–1.73) and among participants with CD4 count ≤ 350 cells/µl (aHR 1.30, 95% CI 1.01–1.67). Depression decreased 6 months after ART initiation (adjusted odds ratio [aOR] 0.34, 95% CI 0.23–0.51). Among East African HIV-infected persons in HIV serodiscordant couples, depression was not a barrier to ART initiation. ART initiation was associated with improved depressive symptoms in this setting.",
keywords = "Africa, Antiretroviral therapy initiation, Depression, HIV",
author = "{Partners Demonstration Project Team} and Jennifer Velloza and Connie Celum and Haberer, {Jessica E.} and Kenneth Ngure and Elizabeth Irungu and Nelly Mugo and Baeten, {Jared M.} and Renee Heffron and Renee Heffron and Deborah Donnell and Ruanne Barnabas and Jessica Haberer and Harald Haugen and Craig Hendrix and Lara Kidoguchi and Mark Marzinke and Susan Morrison and Jennifer Morton and Norma Ware and Monique Wyatt",
note = "Funding Information: The Partners Demonstration Project was funded by the National Institute of Mental Health of the US National Institutes of Health (Grant R01 MH095507), the Bill & Melinda Gates Foundation (Grant OPP1056051), and through the US Agency for International Development (cooperative agreement AID-OAA-A-12-00023). Gilead Sciences donated the PrEP medication but had no role in data collection or analysis. The results and interpretation presented here do not necessarily reflect the views of the study funders. Funding Information: The authors thank the couples who participated in the study and the teams at the four study sites and the University of Washington that supported data collection and management for this work. Coordinating Center (University of Washington) and collaborating investigators (Harvard Medical School, Johns Hopkins University, Massachusetts General Hospital): Jared Baeten (protocol chair), Connie Celum (protocol co-chair), Renee Heffron (project director), Deborah Donnell (statistician), Ruanne Barnabas, Jessica Haberer, Harald Haugen, Craig Hendrix, Lara Kidoguchi, Mark Marzinke, Susan Morrison, Jennifer Morton, Norma Ware, Monique Wyatt. Project sites: Kabwohe, Uganda (Kabwohe Clinical Research Centre): Stephen Asiimwe, Edna Tindimwebwa Kampala, Uganda (Makerere University): Elly Katabira, Nulu Bulya Kisumu, Kenya (Kenya Medical Research Institute): Elizabeth Bukusi, Josephine Odoyo Thika, Kenya (Kenya Medical Research Institute, University of Washington): Nelly Rwamba Mugo, Kenneth Ngure Data Management was provided by DF/Net Research, Inc. (Seattle, WA). PrEP medication was donated by Gilead Sciences. The Partners Demonstration Project was funded by the National Institute of Mental Health of the US National Institutes of Health (Grant R01 MH095507), the Bill & Melinda Gates Foundation (Grant OPP1056051), and through the US Agency for International Development (cooperative agreement AID-OAA-A-12-00023). Gilead Sciences donated the PrEP medication but had no role in data collection or analysis. The results and interpretation presented here do not necessarily reflect the views of the study funders.s Publisher Copyright: {\textcopyright} 2017, Springer Science+Business Media, LLC.",
year = "2017",
month = aug,
day = "1",
doi = "10.1007/s10461-017-1829-z",
language = "English (US)",
volume = "21",
pages = "2509--2518",
journal = "AIDS and Behavior",
issn = "1090-7165",
publisher = "Springer New York",
number = "8",
}